← SynDRA
PF-8380
SynDRA canonical compound SYN1398132 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ENPP2 |
|---|
| Mechanism of action | autotaxin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- PF8380
- T582DIM5A4
- 2(3H)-Benzoxazolone, 6-(1-oxo-3-(1-piperazinyl)propyl)-
- RefChem:172294
- MFCD20527274
- C22H21Cl2N3O5
- 6ZO
- Atx Inhibitor III
- UNII-T582DIM5A4
- MLS006010144
- GTPL9142
- orb1303978
- SCHEMBL3054811
- EX-A137
- GLXC-03728
- HMS3740G07
- BDBM50187693
- s8218
- AKOS016011387
- CCG-269523
- compound 4 [PMID: 23300119]
- CS-0591
- compound 21 [PMID: 26745766]
- NCGC00346939-01
- NCGC00346939-04
- NCGC00346939-05
- NCGC00346939-06
- AC-32916
- AS-40376
- FP157997
- HY-13344
- PF-8380?
- SMR004701264
- T3631
- F861533
- BRD-K50865540-001-01-5
- 6-(3-(Piperazin-1-yl)propanoyl)-benzo[d]oxazol-2(3H)-one
- (3,5-dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate
- 4-[3-Oxo-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propyl]piperazine-1-carboxylic acid 3,5-dichlorobenzyl ester
Look up PF-8380 in the interactive SynDRA portal →